| # | Drug | Count |
|---|---|---|
| 0 | FLUDARABINE PHOSPHATE | 1164 |
| 1 | MYCOPHENOLATE MOFETIL | 1073 |
| 2 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1073 |
| 3 | CYCLOSPORINE | 1040 |
| 4 | TACROLIMUS | 977 |
| 5 | CYCLOPHOSPHAMIDE | 893 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 893 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 893 |
| 8 | METHOTREXATE SODIUM | 884 |
| 9 | METHOTREXATE | 843 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NARSOPLIMAB | 2 | 0.0952 |
| 1 | TREOSULFAN | 213 | 0.0772 |
| 2 | BRINCIDOFOVIR | 8 | 0.0576 |
| 3 | THIOTEPA | 464 | 0.0475 |
| 4 | BUSULFAN | 599 | 0.0376 |
| 5 | ANTIFUNGAL LIQUID SPRAY | 7 | 0.0372 |
| 6 | FLUDARABINE PHOSPHATE | 1164 | 0.0292 |
| 7 | TOLNAFTATE 1% | 8 | 0.0276 |
| 8 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 221 | 0.0272 |
| 9 | AMPICILLIN SODIUM, SULBACTAM SODIUM | 1 | 0.0263 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 1373 |
| 1 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1040 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 843 |
| 3 | Corticosteroid [EPC] | 841 |
| 4 | Azole Antifungal [EPC] | 343 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 337 |
| 6 | Kinase Inhibitor [EPC] | 238 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 234 |
| 8 | Immunoglobulin G [EPC] | 234 |
| 9 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 204 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 6 | 0.0154 |
| 1 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 43 | 0.0132 |
| 2 | Echinocandin Antifungal [EPC] | 100 | 0.0122 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 234 | 0.0121 |
| 4 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1040 | 0.0080 |
| 5 | Photoactivated Radical Generator [EPC] | 1 | 0.0078 |
| 6 | Alkylating Drug [EPC] | 1373 | 0.0056 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 110 | 0.0049 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 62 | 0.0048 |
| 9 | Chemokine Receptor Type 4 Interaction [EPC] | 6 | 0.0044 |